Cargando…
GERANYLGERANYLACETONE ATTENUATES CISPLATIN-INDUCED REDUCTIONS IN CELL VIABILITY BY SUPPRESSING THE ELEVATION OF INTRACELLULAR P53 CONTENT WITHOUT HEAT SHOCK PROTEIN INDUCTION
Geranylgeranylacetone (GGA) was originally used as an anti-ulcer drug to protect gastric mucosa from various stresses, and it is also known to induce heat shock proteins (HSPs), especially HSP70. However, it remains unclear how GGA affects cellular functions in the presence of anti-cancer drugs. We...
Autores principales: | HASEGAWA, MOTOFUSA, ISHIGURO, KAZUHIRO, ANDO, TAKAFUMI, GOTO, HIDEMI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nagoya University
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831257/ https://www.ncbi.nlm.nih.gov/pubmed/22515118 |
Ejemplares similares
-
Protective effect of geranylgeranylacetone, an inducer of heat shock protein 70, against drug-induced lung injury/fibrosis in an animal model
por: Fujibayashi, Takayoshi, et al.
Publicado: (2009) -
Geranylgeranylacetone attenuates hepatic fibrosis by increasing the expression of heat shock protein 70
por: HE, WEI, et al.
Publicado: (2015) -
Induction of Heat-Shock Protein 70 Expression by Geranylgeranylacetone Shows Cytoprotective Effects in Cardiomyocytes of Mice under Humid Heat Stress
por: Wang, Xiaowu, et al.
Publicado: (2014) -
Role of heat shock protein 22 in the protective effect of geranylgeranylacetone in response to oxidized-LDL
por: Gong, Ren, et al.
Publicado: (2019) -
Novel application of low pH-dependent fluorescent dyes to examine colitis
por: Ishiguro, Kazuhiro, et al.
Publicado: (2010)